SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences - Quaterly Results

02 Aug 2024 Evaluate
The sales for the June 2024 quarter moved down to Rs. 734.66 millions as compared to Rs. 803.45 millions during the year-ago period.Net Profit recorded in the quarter ended June 2024 rise to 30.30% to Rs. 84.32  millions  compared to R. 64.71 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 145.54 millions from 122.24 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 734.66 803.45 -8.56 734.66 803.45 -8.56 2851.55 2540.00 12.27
Other Income 10.57 8.59 23.05 10.57 8.59 23.05 42.62 53.23 -19.93
PBIDT 145.54 122.24 19.06 145.54 122.24 19.06 516.03 602.09 -14.29
Interest 11.26 9.42 19.53 11.26 9.42 19.53 50.93 64.97 -21.61
PBDT 134.28 112.82 19.02 134.28 112.82 19.02 465.10 537.12 -13.41
Depreciation 21.23 25.48 -16.68 21.23 25.48 -16.68 97.78 97.88 -0.10
PBT 113.05 87.34 29.44 113.05 87.34 29.44 367.32 439.24 -16.37
TAX 28.73 22.63 26.96 28.73 22.63 26.96 95.73 115.82 -17.35
Deferred Tax 0.02 -1.04 -101.92 0.02 -1.04 -101.92 -0.62 8.55 -107.25
PAT 84.32 64.71 30.30 84.32 64.71 30.30 271.59 323.42 -16.03
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 19.81 15.21 30.21 19.81 15.21 30.21 18.10 23.70 -23.66

Hester Biosciences Share Price

1492.80 20.80 (1.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×